Lynn Durham

Person

Geneva, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical composition for the treatment of autism
- Patent number 11,439,627
- Issue date Sep 13, 2022
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of identifying ASD phenotype 1 patients
- Patent number 11,364,311
- Issue date Jun 21, 2022
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Challenge test for diagnosing subtypes of ASD
- Patent number 11,357,871
- Issue date Jun 14, 2022
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of a subtype of ASD
- Patent number 11,040,117
- Issue date Jun 22, 2021
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for the treatment of autism
- Patent number 10,940,140
- Issue date Mar 9, 2021
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BIOMARKER ASSAY FOR USE IN MONITORING AUTISM
- Publication number 20240011071
- Publication date Jan 11, 2024
- Stalicla S.A.
- Lynn Durham
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER
- Publication number 20230134747
- Publication date May 4, 2023
- STALICLA SA
- Lynn DURHAM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHALLENGE TEST FOR DIAGNOSING A SUBTYPE OF AUTISM SPECTRUM DISEASE
- Publication number 20210187127
- Publication date Jun 24, 2021
- STALICLA SA
- Lynn DURHAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF A SUBTYPE OF ASD
- Publication number 20210169993
- Publication date Jun 10, 2021
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM
- Publication number 20210154177
- Publication date May 27, 2021
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM
- Publication number 20210145803
- Publication date May 20, 2021
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKER ASSAY FOR USE IN MONITORING AUTISM
- Publication number 20200325519
- Publication date Oct 15, 2020
- STALICLA SA
- Lynn Durham
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF IDENTIFYING ASD PHENOTYPE 1 PATIENTS
- Publication number 20190134229
- Publication date May 9, 2019
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM
- Publication number 20190134011
- Publication date May 9, 2019
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHALLENGE TEST FOR DIAGNOSING SUBTYPES OF ASD
- Publication number 20190134230
- Publication date May 9, 2019
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF A SUBTYPE OF ASD
- Publication number 20190134152
- Publication date May 9, 2019
- Stalicla S.A.
- Lynn Durham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lynn Durham

Person

Patents Grantslast 30 patents

Pharmaceutical composition for the treatment of autism

Method of identifying ASD phenotype 1 patients

Challenge test for diagnosing subtypes of ASD

Treatment of a subtype of ASD

Pharmaceutical composition for the treatment of autism

Patents Applicationslast 30 patents

BIOMARKER ASSAY FOR USE IN MONITORING AUTISM

COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER

CHALLENGE TEST FOR DIAGNOSING A SUBTYPE OF AUTISM SPECTRUM DISEASE

TREATMENT OF A SUBTYPE OF ASD

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

BIOMARKER ASSAY FOR USE IN MONITORING AUTISM

METHOD OF IDENTIFYING ASD PHENOTYPE 1 PATIENTS

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

CHALLENGE TEST FOR DIAGNOSING SUBTYPES OF ASD

TREATMENT OF A SUBTYPE OF ASD